StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) bonds

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Allarity Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Allarity Therapeutics's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Convertible Promissory Note Due To Novartis
Convertible
5.00%$1.00M$1.35M
Streeterville A1 Note9.00%$10.93M–
Streeterville B Note5.00%$10.00M–
Streeterville Note––$20.86M
The20243i Convertible Senior Promissory Notes
Convertible at $210 a share
–$660.00K–
The20243i Convertible Senior Promissory Notes
Convertible
8.00%––

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?